Literature DB >> 8546569

Simplified inflow control using stapling devices for major hepatic resection.

K Yanaga1, T Nishizaki, K Yamamoto, A Taketomi, T Matsumata, K Takenaka, K Sugimachi.   

Abstract

We describe the efficacy of a new technique for hepatic inflow division using stapling devices in major hepatic resections. We studied 28 consecutive patients who underwent major hepatic resection at a tertiary referral center by en masse inflow control of Glisson's pedicle in 1993 and 1994, of whom 10 underwent inflow control with stapling devices. Although stapling devices were used for larger tumors (mean +/- SD, 12.2 +/- 8.6 vs 5.7 +/- 5.0 cm; P = .02), the operation time (261 +/- 57 vs 301 +/- 143 minutes), operative blood loss (2071 +/- 1318 vs 4792 +/- 6586 mL), postoperative intra-abdominal bleeding (0% [0/10] vs 17% [3/18]), and hospital stay (16.0 +/- 2.6 vs 20.6 +/- 7.4 days) were favorable for resections with staplers vs resections without staplers; the overall incidences of postoperative complications (40% [4/10] vs 39% [7/18]) and hospital death (10% [1/10] vs 6% [1/18]) were comparable in the two groups. We conclude that stapling devices allow simple, quick, and safe en masse inflow control in major hepatic resections.

Entities:  

Mesh:

Year:  1996        PMID: 8546569     DOI: 10.1001/archsurg.1996.01430130106025

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Simplified hepatic resections with the use of a Chang's needle.

Authors:  Yu-Chung Chang; Naofumi Nagasue; Chu-San Chen; Xi-Zhang Lin
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Right hepatic lobectomy using the staple technique in 101 patients.

Authors:  Fady K Balaa; T Clark Gamblin; Allan Tsung; J Wallis Marsh; David A Geller
Journal:  J Gastrointest Surg       Date:  2007-08-15       Impact factor: 3.452

Review 3.  Rationality and necessity of vascular stapler application during liver resection (Review).

Authors:  Er-Lei Zhang; Zhi-Yong Huang; Xiao-Ping Chen
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.